이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2025. 3. 25.1 분 읽기
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
로컬 자동 번역 · 원본 출처 언어
요약
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) was delayed until March 21, 2025. Additional time is needed for review; therefore, the delay is extended for an additional 60 days.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →